Five-year safety and efficacy of belatacept in renal transplantation

Journal of the American Society of Nephrology

Volumn 21, Issue 9, 2010, Pages 1587-1596

  Vincenti, Flavio ^a   Blancho, Gilles ^b   Durrbach, Antoine ^c   Friend, Peter ^d   Grinyo, Josep ^e   Halloran, Philip F ^f   Klempnauer, Jurgen ^g   Lang, Philippe ^h   Larsen, Christian P ⁱ   Mühlbacher, Ferdinand ^j   Nashan, Björn ^k   Soulillou, Jean Paul ^b   Vanrenterghem, Yves ^l   Wekerle, Thomas ^j   Agarwal, Mamta ^m   Gujrathi, Sheila ^m   Shen, Jinshan ^m   Shi, Rebecca ^m   Townsend, Robert ^m   Charpentier, Bernard ^c,n  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF BARCELONA   (Spain)

^f UNIVERSITY OF ALBERTA   (Canada)

^g Diakoniekrankenhaus Henriettenstiftung gGmbH   (Germany)

^h UNIVERSITÉ PARIS EST CRÉTEIL   (France)

ⁱ EMORY UNIVERSITY   (United States)

^j MEDICAL UNIVERSITY OF VIENNA   (Austria)

^k UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^l UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^m BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

ⁿ BICÊTRE HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; BELATACEPT; CD86 ANTIGEN; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; ABATACEPT; ANTIBODY CONJUGATE; IMMUNOSUPPRESSIVE AGENT;

ABDOMINAL PAIN; ANEMIA; ARTHRALGIA; ARTICLE; BACKACHE; BASAL CELL CARCINOMA; BREAST CANCER; BRONCHITIS; CARDIOVASCULAR RISK; COUGHING; DIARRHEA; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; DRUG SUBSTITUTION; FEVER; FLU LIKE SYNDROME; GASTROENTERITIS; GASTROINTESTINAL DISEASE; GLOMERULUS FILTRATION RATE; HEADACHE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFLUENZA; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIMB PAIN; LONG TERM CARE; LYMPHOPROLIFERATIVE DISEASE; MAXIMUM PLASMA CONCENTRATION; NAUSEA; OSTEOPENIA; PANCREATITIS; PERIPHERAL EDEMA; PNEUMONIA; PRIORITY JOURNAL; PYELONEPHRITIS; RENAL PROTECTION; RHINOPHARYNGITIS; SQUAMOUS CELL CARCINOMA; TIME TO MAXIMUM PLASMA CONCENTRATION; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VOMITING; ACUTE DISEASE; ADULT; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; CONTROLLED STUDY; GRAFT REJECTION; IMMUNOLOGY; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL;

ACUTE DISEASE; ADULT; ANTIGENS, CD86; CARDIOVASCULAR DISEASES; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; HUMANS; IMMUNOCONJUGATES; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION;

EID: 77956528156     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2009111109     Document Type: Article

References (25)

1. The United States Renal Data System 2008 Annual Data Report. Available at: http://www.usrds.org/research-2008.htm. Accessed July 15, 2009
2. Meier-Kriesche HU, Schold JD, Kaplan B: Long-term renal allograft survival: Have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 4: 1289-1295, 2004
3. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB: Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 346: 580-590, 2002 (Pubitemid 34438820)
4. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Chapman JR, Allen RD: Calcineurin inhibitor nephrotoxicity: Longitudinal assessment by protocol histology. Transplantation 78: 557-565, 2004
5. Miller LW: Cardiovascular toxicities of immunosuppressive agents. Am J Transplant 2: 807-818, 2002
6. Larsen CP, Pearson TC, Adams AB, Tso P, Shirasugi N, Strobertm E, Anderson D, Cowan S, Price K, Naemura J, Emswiler J, Greene J, Turk LA, Bajorath J, Townsend R, Hagerty D, Linsley PS, Peach RJ: Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties. Am J Transplant 5: 443-453, 2005
7. Vincenti F, Larsen C, Durrbach A, Wekerle T, Nashan B, Blancho G, Lang P, Grinyo J, Halloran PF, Solez K, Hagerty D, Levy E, Zhou W, Natarajan K, Charpentier B, Belatacept Study Group: Costimulation blockade with belatacept in renal transplantation. N Engl J Med 353: 770-781, 2005 (Pubitemid 41215486)
8. Grinyó J, Larsen C, Charpentier B, Pestana JM, Vanrenterghem Y, Vincenti FG, Di Russo G, Shi R: One year safety profile of belatacept in kidney transplant patients (BENEFIT and BENEFIT-EXT). Poster presented at the annual meeting of the American Society of Nephrology; October 27 through November 1, 2009; San Diego, CA
9. Gill JS, Tonelli M, Mix CH, Pereira BJ: The change in allograft function among long-term kidney transplant recipients. J Am Soc Nephrol 14: 1636-1642, 2003 (Pubitemid 36687067)
10. Gaspari F, Ferrari S, Stucchi N, Centemeri E, Carrara F, Pellegrino M, Gherardi G, Gotti E, Segoloni G, Salvadore M, Rigotti P, Valente U, Donati D, Sandrini S, Sparacino V, Remuzzi G, Perico N, MY.S.S. Study Investigators: Performance of different prediction equations for estimating renal function in kidney transplantation. Am J Transplant 4: 1826-1835, 2004
11. Marcén R, Pascual J, Tenorio M, Ocaña EJ, Teruel JL, Villafruela JJ, Fernández M, Burgos FJ, Ortuño J: Chronic kidney disease in renal transplant recipients. Transplant Proc 37: 3718-3720, 2005 (Pubitemid 43015144)
12. de Bruijne MH, Sijpkens YW, Paul LC, Westendrop RG, van Houwelingen AC, Zwinderman AH: Predicting kidney graft failure using time-dependent renal function covariates. J Clin Epidemiol 56: 448-455, 2003
13. Vincenti F, Jensik SC, Filo RS, Miller J, Pirsch J: A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: Evidence for improved allograft survival at five years. Transplantation 73: 775-782, 2002 (Pubitemid 34260577)
14. Ekberg H, Bernasconi C, Tedesco-Silva H, Vitko S, Hugo C, Demirbas A, Acevedo RR, Grinyó J, Frei U, Vanrenterghem Y, Daloze P, Halloran P: Calcineurin inhibitor minimization in the Symphony Study: Observational results 3 years after transplantation. Am J Transplant 9: 1876, 2009
15. de Mattos AM, Prather J, Olyaei AJ, Shibagaki Y, Keith DS, Mori M, Norman DJ, Becker T: Cardiovascular events following renal transplantation: Role of traditional and transplant-specific risk factors. Kidney Int 70: 757-764, 2006 (Pubitemid 44215352)
16. Abbott KC, Yuan CM, Taylor AJ, Cruess DF, Agodoa LY: Early renal insufficiency and hospitalized heart disease after renal transplantation in the era of modern immunosuppression. J Am Soc Nephrol 14: 2358-2365, 2003
17. Gourishankar S, McDermid JC, Jhangri GS, Preiksaitis JK: Herpes zoster infection following solid organ transplantation: Incidence, risk factors and outcomes in the current immunosuppressive era. Am J Transplant 4: 108-115, 2004 (Pubitemid 38155496)
18. Abbott KC, Swanson SJ, Richter ER, Bohen EM, Agodoa LY, Peters TG, Barbour G, Lipnick R, Cruess DF: Late urinary tract infection after renal transplantation in the United States. Am J Kidney Dis 44: 353-362, 2004
19. Becker BN, Becker YT, Leverson GE, Simmons WD, Sollinger HW, Pirsch JD: Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation. Am J Kidney Dis 39: 1088-1095, 2002
20. Bonvoisin C, Weekers L, Xhignesse P, Grosch S, Milicevic M, Krzesinski JM: Polyomavirus in renal transplantation: a hot problem. Transplantation 85[Suppl]: S42-S48, 2008 (Pubitemid 351521161)
21. Vincenti F, Charpentier B, Vanrenterghan Y, Rostaing L, Bresnahan B, Darji P, Massari P, Mondragon-Ramirez GA, Agarwal M, Di Russo G, Lin C-S, Garg P, Larsen CP: A phase III study of belatacept-based immunosuppression regimens vs cyclosporine in renal transplant recipients (BENEFIT study). Am J Transplant 10: 535-546, 2010
22. Durrbach, Pestana JM, Pearson T, Vincenti F, Duro Gardia V, Campistol J, del Carmen Rial M, Florman S, Block A, Di Russo G, Xing J, Garg P, Grinyó J: A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study). Am J Transplant 10: 547-557, 2010
23. Latek R, Fleener C, Lamian V, Kulbokas E 3rd, Davis PM, Suchard SJ, Curran M, Vincenti F, Townsend R: Assessment of belatacept-mediated costimulation blockade through evaluation of CD80/86-receptor saturation. Transplantation 87: 926-933, 2009
24. 2008 Annual Report of the U.S. Organ Procurement Network/Scientific Registry of Transplant Recipients: Transplant Data 1998-2007, Rockville, US Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, 2008
25. Grinyó J, Marks W, Vincenti F, Kaufman DB, Marder BA, Woodle ES, Citterior F, Agarwal M, Dong Y, Garg P, Ferguson R: Immunosuppression with belatacept-based, CNI-free, steroid-avoiding regimens in kidney transplant recipients: Six month interim results. Presented at the American Transplant Congress; May 30 through June 3, 2009; Boston, MA